NATERA, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NATERA, INC. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $0.00.
- NATERA, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $235.44M.
- NATERA, INC. stock issued during period, value, new issues for the quarter ending 2021-12-31 was $0.00.
- NATERA, INC. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $550.82M, a 103.52% increase year-over-year.
- NATERA, INC. stock issued during period, value, new issues for fiscal 2023 was $235.44M, a 45.65% decline from fiscal 2022.
- NATERA, INC. stock issued during period, value, new issues for fiscal 2022 was $433.19M, a 21.36% decline from fiscal 2021.
- NATERA, INC. stock issued during period, value, new issues for fiscal 2021 was $550.82M, a 103.52% increase from fiscal 2020.
- NATERA, INC. stock issued during period, value, new issues for fiscal 2020 was $270.65M, a 16.31% decline from fiscal 2019.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $235.44M 10-K · filed 2026-02-27 |
| 2023-09-30 | $235.44M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $433.19M 10-K · filed 2025-02-28 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $550.82M 10-K · filed 2024-02-29 |
| 2021-09-30 | $550.82M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $270.65M 10-K · filed 2023-03-01 |
| 2020-09-30 | $270.65M 10-Q · filed 2021-11-05 | |
| 2019-12-31 | $215.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $323.41M 10-K · filed 2022-02-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | |
| 2019-06-30 | $107.59M 10-Q · filed 2020-08-07 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $96.78M 10-K · filed 2021-02-26 |
| 2018-09-30 | $96.78M 10-Q · filed 2019-11-08 | |
| 2015-12-31 | $182.47M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |